Consistently, Naticol®Gut also significantly reduced the secretion of IFN-γ, TNF-α, IL-1β, IL-6, and CXCL-10 pro-inflammatory mediators in human blood monocytes from IBD patients (Fig. 8b). This evidence concerns the gene CXCL10 and inflammatory bowel disease.